Opinion
Video
Author(s):
Dr Linhares discusses newer combination therapies for the treatment of patients with chronic lymphocytic leukemia, highlighting ibrutinib and venetoclax, which is being studied in the CAPTIVATE trial.
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Why Hope is Important For Patients with Chronic Lymphocytic Leukemia
The Treatment Journey of a Patient with CLL
Waiting for Results After My CLL Diagnosis
Learning to ‘Let it Be’ After Poor Test Results